CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Participants who were previously Viome costumers who signed informed consent to participate and self reported type 2 diabetes or pre-diabetes...
Bothell, Washington, United States
Participants will be randomized to receive the Companeros en Salud diabetes self-management education and support (DSMES) intervention with ...
Seattle, Washington, United States and 1 other location
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Seattle, Washington, United States and 18 other locations
The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...
Phase 4
Tacoma, Washington, United States and 9 other locations
A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ technology in adults with type 2 diabetes using b...
Seattle, Washington, United States and 20 other locations
OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...
Phase 2
Seattle, Washington, United States and 24 other locations
of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...
Phase 4
Seattle, Washington, United States and 35 other locations
Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled with insulin therapy. The purpose of ...
Seattle, Washington, United States and 62 other locations
INHALE-3 is a Phase 4, randomized controlled trial (RCT) that will randomly assign participants ≥18 years of age with type 1 diabetes (T1D) ...
Phase 4
Seattle, Washington, United States and 18 other locations
study is to measure the safety and efficacy of insulin efsitora alfa (LY3209590) compared with insulin degludec in participants with type 1 diabetes...
Phase 3
Renton, Washington, United States of America and 76 other locations
Clinical trials
Research sites
Resources
Legal